Experimental Ebola drug on its way to Liberia
Written by Najib

 

The government of Liberia says that sample doses of the experimental Ebola drug ZMapp will be sent there to treat doctors who have contracted the deadly virus.

The White House and Food and Drug Administration approved the Liberian request for the drug to be made available to them.

Liberia identified itself as the recipient of the drug after the company that makes ZMapp said earlier that its supply was exhausted after fulfilling the request of a West African country, which it did not name. The delivery of the ZMapp to Liberia follows a request made on Friday from Liberian President Ellen Johnson Sirleaf to President Barack Obama.

The sample doses will be brought to Liberia by a U.S. government representative this week, the Liberian government said. [Link]